Patents by Inventor Anthony Killian

Anthony Killian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Surfactant treatment regimen
    Patent number: 7541331
    Abstract: Regimens for the therapeutic or prophylactic administration of pulmonary surfactant to infants exhibiting or at risk of developing bronchopulmonary dysplasia are disclosed.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: June 2, 2009
    Assignee: Discovery Laboratories, Inc.
    Inventors: Anthony Killian, Christopher Schaber, Robert Segal, Carlos Guardia
  • Surfactant treatment regimen
    Publication number: 20060194728
    Abstract: Regimens for the therapeutic or prophylactic administration of pulmonary surfactant to infants exhibiting or at risk of developing bronchopulmonary dysplasia are disclosed.
    Type: Application
    Filed: January 6, 2006
    Publication date: August 31, 2006
    Inventors: Anthony Killian, Christopher Schaber, Robert Segal, Carlos Guardia
  • Method of treating chronic obstructive pulmonary disease
    Patent number: 6020380
    Abstract: A class of .OMEGA.-substituted-1,4-benzoquinon-2-yl]alkanoic acids are useful in the treatment of chronic obstructive pulmonary disease (COPD). The preferred compound for the method of treatment is 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid or a pharmaceutically acceptable salt, ester or pro-drug thereof.
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: February 1, 2000
    Assignee: Tap Holdings Inc.
    Inventor: Anthony Killian
  • Method of treating preeclampsia
    Patent number: 5534548
    Abstract: Straight-chain alkanoic acids, substituted at the .OMEGA.-carbon atom by a substituted phenyl, naphthyl, furyl, or thienyl group and by a substituted 1,4-benzoquinon-2-yl group are effective in the therapy or prophylaxis of conditions associated with lipid peroxide injury to vascular endothelium particularly preeclampsia and eclampsia in pregnant females.
    Type: Grant
    Filed: May 3, 1994
    Date of Patent: July 9, 1996
    Assignee: TAP Pharmaceuticals, Inc.
    Inventor: Anthony Killian